
PHARMA
Astellas, Ambryx Sign US$300 Million Antibody Drug Conjugate Deal
Astellas Pharma Inc. on Thursday entered into a collaboration with Ambrx Inc. for the discovery and development of novel antibody drug conjugates.
Takeda Submits NDA Application For Cell Culture-Based H5N1 Vaccines
Takeda Pharma has submitted New Drug Applications for cell culture-based H5N1 influenza vaccines to the Ministry of Health, Labor and Welfare in Japan.
Sanofi To Invest US$75 million Into Vietnam Manufacturing Facility
Sanofi announced on Friday the official launch of a construction project for a new manufacturing facility in Ho Chi Minh City.
Sinovac Reports PhIII Trial Results For HFMD Vaccine Candidate
Chinese vaccine provider Sinovac Biotech Ltd. has completed a Phase III clinical trial on its Enterovirus 71 vaccine against hand, foot, and mouth disease.
BGI-Shenzhen Acquires US-Based Complete Genomics For $117M
BGI completed today the acquisition of U.S.-based whole human genomic sequencing provider, Complete Genomics, Inc.
Addex, Viva Biotech To Advance GPCR Therapeutics
Addex Therapeutics and Shanghai-based Viva Biotech Ltd. have entered into a partnership to accelerate the advancement of oral allosteric modulators.
Riboxx Pharma, China National Biotec Group To Collaborate On TLR3 Agonist
Riboxx Pharmaceuticals GmbH and China National Biotec Group have initiated a research collaboration to evaluate a TLR3 agonist from Riboxx.
Takeda And Resolve Therapeutics To Develop Lupus Treatments
Takeda Pharma and Resolve Therapeutics have entered into a partnership to develop compounds for the treatment of lupus and other autoimmune diseases.
Inviragen Advances Dengue Vaccine Into Second Stage Of Phase II Study
Inviragen, Inc. has initiated the second stage of an ongoing Phase II study of DENVax™, its investigational dengue vaccine.